Intro

This chapter discusses the latest treatment guidelines for Clostridium difficile, emphasizing the shift towards vancomycin as the first-line therapy due to resistance issues. The conversation also highlights the importance of clear definitions for severe cases and the potential need for surgical intervention in critical situations.